Background: Cardiovascular diseases are prevalent in people with chronic obstructive pulmonary disease (COPD). We hypothesized that endothelial dysfunction could be a marker of the proatherogen status in COPD. Methods and results: We measured endothelial dysfunction by flow-mediated dilation (FMD) and after sublingual administration of nitroglycerin (nitrate-mediated dilation: NMD) in 44 COPD patients and 48 controls. Compared with controls COPD patients had worse mean FMD (5.4% vs 8.2%, P < .001) and NMD (12.0% vs 13.9%, P = .007). FMD was inversely related to FEV1/VC ratio (r = −0.327, P = .030). The negative association between COPD and FMD was confirmed after correction for potential confounders in a multiple linear regression model (β = −0.019, P = .002). In the same model NMD (β = 0.396, P < .001) was positively associated with FMD. Conclusions: Endothelial-dependent and, to a lesser extent, endothelial-independent dilations are significantly impaired in COPD, and the impairment is proportional to the severity of bronchial obstruction.
Murray CJ, Lopez ADAlternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 ;349:1498-1504.
2.
Antonelli Incalzi R., Fuso L., De Rosa M., et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2794-2800.
3.
Sin DD, Man SFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514-1519.
4.
Fuso L., Incalzi RA, Pistelli R., et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995;98:272-277.
5.
Ferrer M., Alonso J., Morera J., et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med. 1997;127:1072-1079.
6.
Hole DJ, Watt GC, Davey-Smith G., Hart CL, Gillis CR, Hawthorne VMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ . 1996;313:711-715.
7.
van Eeden SF , Yeung A., Quinlam K., Hogg JCSystemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:61-67.
8.
Incalzi RA, Bellia V., Catalano F., Scichilone N., Imperiale C., Maggi S., Rengo F.Evaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments: the Salute Respiratoria nell'Anziano (Sa.R.A.)Study. Chest. 2001;120:734-742.
9.
Kim JA, Montagnani M., Koh KK, Quon MJReciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888-1904.
10.
Gan WQ, Man SF, Senthilselvan A., Sin DDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax . 2004;59:574-580.
11.
Ross R.Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
12.
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912-930.
13.
Ward MEDilation of rat diaphragmatic arterioles by flow and hypoxia: roles of nitric oxide and prostaglandins. J Appl Physiol. 1999;86:1644-1650.
14.
Bellia V., Battaglia S., Catalano F., et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123:1066-1072.
15.
Davignon J., Ganz P.Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:11127-11132.
16.
Behrendt D. , Ganz P.Endothelial function. From vascular biology to clinical applications. Am J Cardiol. 2002 ;90:40L-48L.
Corretti MC , Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
19.
O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996;27:224-231.
20.
Meredith IT , Currie KE, Anderson TJ, Roddy MA, Ganz P., Creager MAPostischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide . Am J Physiol . 1996;270:H1435-H1440.
21.
Vita JA, Keaney JF Jr, Larson MG, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004;110: 3604-3609.
22.
Celermajer DS, Sorensen KE, Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149-2155.
23.
Ducharme A. , Dupuis J., McNicoll S., Harel F., Tardif JCComparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am J Cardiol . 1999;84:952-9544, A8.
24.
Adams MR, Robinson J., McCredie R., et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol . 1998;32:123-127.
25.
Gokce N., Holbrook M., Duffy SJ, et al. Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension. 2001;38:1349-1354.
26.
Kato M., Roberts-Thomson P., Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation . 2000;102:2607-2610.
27.
Soler N., Ewig S., Torres A., Filella X., Gonzalez J., Zaubet A.Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J . 1999;14:1015-1022.
28.
Jimenez Ruiz CA, Rajas O., Ruiz A., et al. Bronchoalveolar lavage in smokers: quantification of alveolar macrophages and neutrophils as markers of bronchial obstruction. In Vivo. 1998;12:427-430.
29.
Kathiresan S., Larson MG, Vasan RS, et al. Common genetic variation at the endothelial nitric oxide synthase locus and relations to brachial artery vasodilator function in the community. Circulation . 2005;112:1419-1427.
30.
Sin DD, Lacy P., York E., Man SFEffects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:760-765.
31.
Verma S., Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation . 2002;105: 1890-1896.
32.
Kiechl S., Werner P., Egger G., et al. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke. 2002;33:2170-2176.
33.
Yan RT, Anderson TJ, Charbonneau F., Title L., Verma S., Lonn E.Relationship between carotid artery intimamedia thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol. 2005;45:1980-1986.
34.
Kalinowski L. , Dobrucki LW, Szczepanska-Konkel M., et al. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation. 2003;107:2747-2752.
35.
Lekakis JP, Protogerou A., Papamichael C., et al. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther. 2005;19:277-281.
36.
MacCallum PKMarkers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc. 2005;2:34-43.
37.
Reuben DB, Judd-Hamilton L., Harris TB, Seeman TEThe associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003;51:1125-1130.
38.
Rabinovich RA, Figueras M., Ardite E., et al. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J. 2003;21:789-794.
